The Centers for Medicare & Medicaid Services (CMS) has formally launched the Office of Rural Health Transformation, creating a dedicated hub to oversee a $50 billion, 5-year effort to strengthen rural health systems and expand access to care...
The Centers for Medicare & Medicaid Services (CMS) has formally launched the Office of Rural Health Transformation, creating a dedicated hub to oversee a $50 billion, 5-year effort to strengthen rural health systems and expand access to care...
A new report from the Office of Inspector General (OIG) warns that gaps in NIH oversight have heightened fraud, waste, and abuse risks across its Other Transaction (OT) awards. The findings come amid a rapid expansion of OT use—from under...
A new report from the Office of Inspector General (OIG) warns that gaps in NIH oversight have heightened fraud, waste, and abuse risks across its Other Transaction (OT) awards. The findings come amid a rapid expansion of OT use—from under...
The No Surprises Act (NSA) is shielding Americans from nearly 20 million surprise medical bills each year, but the federal arbitration system intended to resolve payment disputes is being overwhelmed and undermined by large volumes of...
The No Surprises Act (NSA) is shielding Americans from nearly 20 million surprise medical bills each year, but the federal arbitration system intended to resolve payment disputes is being overwhelmed and undermined by large volumes of...
The Centers for Medicare & Medicaid Services (CMS) has finalized new 2026 hospital price transparency rules requiring hospitals nationwide to publish verified, standardized pricing data to empower patients and payers with clearer cost...
The Centers for Medicare & Medicaid Services (CMS) has finalized new 2026 hospital price transparency rules requiring hospitals nationwide to publish verified, standardized pricing data to empower patients and payers with clearer cost...
WASHINGTON, DC — November 6, 2025 — Speaking from the Oval Office, President Donald J. Trump unveiled a sweeping new plan aimed at lowering prescription drug costs and expanding coverage for millions of Americans. The initiative includes...
WASHINGTON, DC — November 6, 2025 — Speaking from the Oval Office, President Donald J. Trump unveiled a sweeping new plan aimed at lowering prescription drug costs and expanding coverage for millions of Americans. The initiative includes...
A new analysis shows that the end of Medicaid’s pandemic-era protections triggered massive disenrollments but only modest rises in uninsurance, revealing sharp differences across states and demographic groups.
A new analysis shows that the end of Medicaid’s pandemic-era protections triggered massive disenrollments but only modest rises in uninsurance, revealing sharp differences across states and demographic groups.
At AMCP Nexus 2025, policy experts Geni Tunstall, JD, and Adam Colborn, JD, provided an in-depth look at the political, legal, and regulatory developments shaping health care over the past year.
At AMCP Nexus 2025, policy experts Geni Tunstall, JD, and Adam Colborn, JD, provided an in-depth look at the political, legal, and regulatory developments shaping health care over the past year.
A new report from the Congressional Budget Office (CBO) projects that expanded exemptions for orphan drugs under the One Big Beautiful Bill Act could cost Medicare an estimated $8.8 billion over 10 years.
A new report from the Congressional Budget Office (CBO) projects that expanded exemptions for orphan drugs under the One Big Beautiful Bill Act could cost Medicare an estimated $8.8 billion over 10 years.
A new nationwide survey conducted by NORC at the University of Chicago underscores the important role pharmacy benefit managers (PBMs) play in helping employers manage prescription drug benefits.
A new nationwide survey conducted by NORC at the University of Chicago underscores the important role pharmacy benefit managers (PBMs) play in helping employers manage prescription drug benefits.
Louisiana’s fierce battle over pharmacy benefit managers has pitted Governor Jeff Landry against CVS, reshaping state contracts, sparking lawsuits, and raising new questions about the future of drug pricing and pharmacy access.
Louisiana’s fierce battle over pharmacy benefit managers has pitted Governor Jeff Landry against CVS, reshaping state contracts, sparking lawsuits, and raising new questions about the future of drug pricing and pharmacy access.
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
In the span of just 9 months, the landscape of administrative law has undergone a transformation so profound that pharmaceutical executives, health care providers, and patients alike are struggling to navigate the new terrain. The Supreme...
In the span of just 9 months, the landscape of administrative law has undergone a transformation so profound that pharmaceutical executives, health care providers, and patients alike are struggling to navigate the new terrain. The Supreme...
Over the past 2 weeks, I’ve examined the growing friction between the Section 232 pharmaceutical tariff investigations and the Medicare drug pricing reforms authorized by the Inflation Reduction Act (IRA). These 2 policy agendas—industrial...
Over the past 2 weeks, I’ve examined the growing friction between the Section 232 pharmaceutical tariff investigations and the Medicare drug pricing reforms authorized by the Inflation Reduction Act (IRA). These 2 policy agendas—industrial...
A Kaiser Family Foundation (KFF) report reveals the significant discrimination and unfair treatment faced by LGBT adults in the US, impacting mental health and access to health care, particularly for younger, lower-income, and women within...
A Kaiser Family Foundation (KFF) report reveals the significant discrimination and unfair treatment faced by LGBT adults in the US, impacting mental health and access to health care, particularly for younger, lower-income, and women within...
Demodex mites were found in the eyelashes of 94% of patients examined with a simple diagnostic technique at a standard ophthalmic practice, according to a study published online in the journal Clinical Ophthalmology.
Demodex mites were found in the eyelashes of 94% of patients examined with a simple diagnostic technique at a standard ophthalmic practice, according to a study published online in the journal Clinical Ophthalmology.
A new study highlights demographic data on subpopulations of people with multiple sclerosis (MS) in the US based on findings from administrative health claims (AHC) data sets.
A new study highlights demographic data on subpopulations of people with multiple sclerosis (MS) in the US based on findings from administrative health claims (AHC) data sets.